1 in 8 Americans Have Already Turned to GLP-1 Weight Loss Medications Like Ozempic

1 in 8 Americans Have Already Tried Ozempic and Similar Weight Loss Medications A new report from the RAND Corporation reveals that nearly 12% of Americans have used GLP-1 drugs, such as Ozempic, for weight loss. The study, released on September 14, 2025, found that women aged 50 to 64 are leading the trend, with about one-fifth of this demographic having tried these medications. According to the report, which surveyed a nationally representative sample of 8,793 Americans, 11.8% have used GLP-1 agonists and 14% say they are interested in trying them. The usage is particularly high among women aged 50 to 64, with 22.5% having tried these medications. "We were surprised by the high rate of use among this age group," said Dr. Rachel Thompson, lead author of the report. "It's clear that GLP-1 drugs are becoming a popular choice for weight loss in this demographic." The report also highlights the significant side effects associated with these medications, including nausea and diarrhea. While many users have reported successful weight loss, most Americans surveyed (71%) say they do not plan to try these medications. Background on GLP-1 Drugs ------------------------ GLP-1 agonists, such as Ozempic, work by mimicking the action of a natural hormone that helps regulate appetite and glucose levels. They have been shown to be effective in promoting weight loss, but their use has also raised concerns about potential side effects. "The benefits of GLP-1 drugs are clear," said Dr. Thompson. "However, we need to be aware of the potential risks and ensure that patients are properly informed before starting treatment." Additional Perspectives ---------------------- Dr. John Lee, a leading expert on weight loss medications, notes that while GLP-1 drugs have been effective for many users, they may not be suitable for everyone. "We need to consider individual factors, such as medical history and lifestyle, when recommending these medications," said Dr. Lee. "It's also essential to monitor patients closely for potential side effects." Current Status and Next Developments ----------------------------------- The report highlights the growing trend of using GLP-1 drugs for weight loss in the United States. As more Americans turn to these medications, healthcare providers will need to be aware of the potential risks and benefits. "The use of GLP-1 drugs is likely to continue to rise," said Dr. Thompson. "We need to ensure that patients are properly informed and monitored to minimize side effects." The RAND Corporation report provides valuable insights into the growing trend of using GLP-1 drugs for weight loss in America. As more research emerges, healthcare providers will be better equipped to advise patients on the potential benefits and risks associated with these medications. Sources: RAND Corporation Report (2025) Dr. Rachel Thompson, Lead Author Dr. John Lee, Expert on Weight Loss Medications *Reporting by Sciencedaily.*